Severe Asthma-1200x630px

An ATS and AAFP Online Education Partnership Program

The prevalence of asthma and severe asthma across your patient population is increasing while 60% of those who have asthma or severe asthma remain uncontrolled.

  • More than 60% of those with an asthma diagnosis do not adhere to their treatment given a variety of healthcare, economic and environmental factors.
  • Up to 35% of all patients diagnosed with asthma or severe asthma do not have asthma or severe asthma.
  • 1.4 deaths per every 100,000 US citizens are related to asthma or severe asthma.

Many patients who may have been misdiagnosed where symptomology presents as asthma or severe asthma have conditions masquerading as asthma or severe asthma. Understanding and properly diagnosing asthma and severe asthma can ensure appropriate diagnosis, improve patient outcomes and decrease the quantity of those who are poorly controlled. Primary Care Practitioners and Specialists can collaboratively work to individualize care and implement effective treatment management plans.

Learn and gain the knowledge and tools you need from subject matter experts via a new AAFP/ATS online education program.

Start the new four module online education program that spans proper diagnosis of asthma and severe asthma, patient communication strategies to increase treatment adherence and maintain control, evidence based and case based planning for diagnosis and treatment and lastly, an overview of the current clinical trial data on the safety and efficacy of existing targeted therapies.

This online education is a must-do for you and all practitioners focused in patient care!

Sign Up and Begin Module One>

Did You Know

  • Close to 1.8 million emergency room visits are attributed to asthma.
  • In 2013, asthma accounted for an estimated 10.1 million lost work days among employed adults.
  • The annual direct healthcare cost of asthma is approximately $50.1 billion; indirect costs (e.g. lost productivity) add another $5.9 billion for a total of $56 billion dollars.
  • In 2016, it was estimated that 20.4 million American adults currently had asthma. Of these, 9.7 million Americans had an asthma flare-up.
  • On average 10% of the population in each of the 50+ States and Territories have asthma or severe asthma.

Source: CDC

What You Need to Know

Lack of treatment adherence across the patient population average of 60% leads to significant increases of frequent and intense episodes resulting in emergency room, clinic and hospital visits. Patients whose asthma is poorly or uncontrolled put pressure on health systems and increase the overall cost of care.

6.2% of all physician office visits are asthma related. Nationwide that represents 600,000 office visits where 391 of every 10,000 children and 278 of every 10,000 adults present and are seeking treatment or where an asthma diagnosis is being managed.

Hidden within the statistics are various proximity to care and socio-economic environmental factors that increase the number of patients with asthma and those of which are poorly controlled.

Uncontrolled or undiagnosed asthma correlates to challenged access to care, particularly access to specialty practitioners.

Gain the knowledge and information you need today from expert faculty, increase your diagnostic skills and learn how to leverage evidence based treatment planning conjoined with the most current treatment options.

Sign up and begin the online educational activity today>

The American Thoracic Society  (ATS) and the American Academy of Family Physicians (AAFP) have partnered to bring you a four module online education program that spans proper diagnosis of asthma and severe asthma, patient communication strategies to increase treatment adherence and maintain control, evidence based and case based planning for diagnosis and treatment and lastly, an overview of the current clinical trial data on the safety and efficacy of existing targeted therapies.

This educational activity is supported by educational grants from AstraZeneca Pharmaceuticals LP and GlaxoSmithKline.

Prevalence and Characteristics of Asthma-Chronic Obstructive Pulmonary Disease Overlap in Routine Primary Care Practices

Most patients with asthma and COPD are treated in the primary care setting, yet little is known about asthma-COPD overlap (ACO) in primary care. This motivated Jerry A. Krishnan and colleagues to analyze for their Sept. AnnalsATS article the medical records of 2,165 patients in the UK’s Optimum Patient Care Research Database who had been diagnosed with either asthma, COPD, or both. They wanted to know how many of these patients would meet the definition of ACO proposed by the Respiratory Effectiveness Group, which represents primary care and specialist clinicians from 14 countries. The group defines ACO as the presence of all of the following:  (1) age ≥40 years; (2) current or former smoking, (3) post-bronchodilator (BD) airflow limitation (forced expired volume in the first second [FEV1] /forced vital capacity [FVC] < 0.7), and (4) ≥12% and ≥200 mL reversibility in post-BD FEV1.

They found that one in five of the patients had ACO, and the most common co-morbid conditions were diabetes, cardiovascular disease, and hypertension. The authors believe their study will be useful for designing clinical trials of different management strategies for ACO in primary care.

Read the Full Article

Placebo Effects in Clinical Trials Evaluating Patients with Uncontrolled Persistent Asthma

In the Sept. AnnalsATS article, Faye Luc and co-authors write that their analysis of five randomized, placebo-controlled clinical trials found a placebo effect on uncontrolled, persistent asthma.  The magnitude of the effect was greatest for health care utilization outcomes, including exacerbations, ER visits, and hospitalizations.  An intermediate effect was seen in patient-reported outcomes, and the smallest effect was seen in FEV1 improvement. No patient subgroups appeared to be differentially susceptible to placebo effects.

The authors suggest possible explanations for the placebo effect, including neurobiological and psychological factors, better clinical monitoring and adherence to baseline medications while in the study, and beneficial changes in lifestyle patients may have undertaken on their own as results of being enrolled in a study.

Read the Full Article